International Assets Investment Management LLC Decreases Stock Holdings in The Clorox Company (NYSE:CLX)

International Assets Investment Management LLC lowered its stake in The Clorox Company (NYSE:CLX) by 81.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 102,326 shares of the company’s stock after selling 436,250 shares during the quarter. Clorox accounts for 0.8% of International Assets Investment Management LLC’s portfolio, making the stock its 13th largest position. International Assets Investment Management LLC owned about 0.08% of Clorox worth $16,619,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently made changes to their positions in the company. Insight Folios Inc lifted its holdings in shares of Clorox by 3.0% in the third quarter. Insight Folios Inc now owns 2,195 shares of the company’s stock worth $358,000 after buying an additional 63 shares in the last quarter. Fiduciary Group LLC grew its position in shares of Clorox by 0.4% during the second quarter. Fiduciary Group LLC now owns 19,050 shares of the company’s stock valued at $2,600,000 after purchasing an additional 72 shares in the last quarter. GHP Investment Advisors Inc. lifted its position in shares of Clorox by 2.0% in the second quarter. GHP Investment Advisors Inc. now owns 3,634 shares of the company’s stock worth $496,000 after buying an additional 72 shares in the last quarter. SPC Financial Inc. boosted its stake in Clorox by 2.2% during the second quarter. SPC Financial Inc. now owns 3,485 shares of the company’s stock valued at $476,000 after buying an additional 75 shares during the last quarter. Finally, Massmutual Trust Co. FSB ADV grew its holdings in Clorox by 17.2% during the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 510 shares of the company’s stock valued at $83,000 after buying an additional 75 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have issued reports on CLX. TD Cowen upgraded Clorox from a “sell” rating to a “hold” rating and upped their price objective for the company from $155.00 to $170.00 in a research report on Wednesday, November 6th. Evercore ISI decreased their price target on Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research note on Monday, October 14th. StockNews.com lowered Clorox from a “buy” rating to a “hold” rating in a research note on Sunday. DA Davidson boosted their target price on shares of Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a research note on Monday, November 4th. Finally, Jefferies Financial Group upgraded shares of Clorox from a “hold” rating to a “buy” rating and lifted their price objective for the company from $174.00 to $187.00 in a report on Tuesday, October 1st. Four equities research analysts have rated the stock with a sell rating, ten have given a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, Clorox currently has a consensus rating of “Hold” and an average target price of $157.46.

Clorox Stock Performance

CLX stock traded up $0.43 during midday trading on Wednesday, hitting $160.13. 109,948 shares of the stock traded hands, compared to its average volume of 887,935. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $171.37. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The stock’s fifty day simple moving average is $164.64 and its 200-day simple moving average is $155.33. The firm has a market cap of $19.82 billion, a P/E ratio of 55.79, a PEG ratio of 3.04 and a beta of 0.42.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The business had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same period in the previous year, the business earned $0.49 earnings per share. The business’s revenue was up 27.0% compared to the same quarter last year. On average, analysts expect that The Clorox Company will post 6.85 earnings per share for the current year.

Clorox Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be issued a $1.22 dividend. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a yield of 3.05%. Clorox’s payout ratio is 170.03%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.